Loading
companiesCompany
McKesson / The US Oncology Network
McKesson runs the largest US community oncology network (about 3,000 providers) and distributes drugs, and co-owns the Sarah Cannon Research Institute.
Also called: US Oncology Research
Overview
McKesson, based in Irving, Texas, and listed as MCK, runs The US Oncology Network, the largest US community oncology network with about three thousand providers, distributes cancer drugs, and co-owns the Sarah Cannon Research Institute. Its offerings span practice management, the Value Pathways treatment pathways, the Ontada data business and research through SCRI, with McKesson Ventures also linked. OnCo connects it to community oncology and site networks and to oncology EHR and real-world data platforms. Whether a drug distributor that also owns treatment pathways and practices can keep those pathways independent is the fair question. Sarah Cannon has its own page.
Similar pages
- CompanyFlorida Cancer Specialists & Research Institute
Shares Community oncology and site networks and the tag supporting.
- CompanyOneOncology
Shares Community oncology and site networks and the tag supporting.
- CompanyConcertAI
Shares Oncology EHR and real-world data platforms and the tag supporting.
- CompanyCOTA
Shares Oncology EHR and real-world data platforms and the tag supporting.
- CompanyDatavant
Shares Oncology EHR and real-world data platforms and the tag supporting.
- CompanyKomodo Health
Shares Oncology EHR and real-world data platforms and the tag supporting.
- CompanyEpic Systems
Shares Oncology EHR and real-world data platforms and the tag supporting.
- CompanyTriNetX
Shares Oncology EHR and real-world data platforms and the tag supporting.
fronts
technologies
companies
trials
Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia PatientsPhII ICb With/Without Erbitux in MBC PtsStudy of Selinexor Plus DRd for Newly Diagnosed Multiple MyelomaTrial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer
Software in use
The software of oncology →Commercial and regulated products that this organisation sells. Each card says what is behind it: a regulator's database, the literature, a public body's list, or only the company's own words. Listing is not endorsement, and a clearance is a regulatory fact, not a clinical one.
McKesson's oncology data and technology arm, built around the iKnowMed practice record used across The US Oncology Network.
McKesson / The US Oncology Networkno source outside the company found